PKMYT1 inhibitor (RP-6306), modulates the cell cycle progression and induces PANoptosis in pancreatic cancer cells, thereby inhibiting tumor growth and proliferation both in vitro and in vivo. Here, PKMYT1 is linked to pancreatic neoplasm.